


Integro Theranostics Revenue
Biotechnology Research • 16052 Swingley Ridge Rd, 300, United States • 1-10 Employees
Integro Theranostics revenue & valuation
| Annual revenue | $598,885 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,000,000 |
| Total funding | No funding |
Key Contact at Integro Theranostics
Tito Gonzalez
Chief Technology Officer
Company overview
| Headquarters | 16052 Swingley Ridge Rd, 300, St. Louis, Missouri 63017, US |
| Website | |
| NAICS | 541714 |
| Founded | 2020 |
| Employees | 1-10 |
Integro Theranostics Email Formats
Integro Theranostics uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@integrotheranostics.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@integrotheranostics.com | 100% |
About Integro Theranostics
Integro Theranostics is a clinical stage company developing fluorescent imaging agents and associated medical devices that enable surgeons to readily see and remove cancerous tissue. This accurate, real-time visualization of cancer tissue facilitates a more complete removal of cancer during surgery. Integro Theranostics was born out of a collaboration between Kingdom Capital (values based private investment company) and Washington University School of Medicine. We are combining the clinical infrastructure of a top research medical center, the technology of a world renowned scientist, and the resources of Kingdom Capital to commercialize this transformative technology and improve surgical outcomes for cancer patients.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Integro Theranostics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Integro Theranostics has never raised funding before.
Frequently asked questions
4.8
40,000 users



